To Test a New Drug (LCFA-01) for Safety and PK in Healthy Adults for Bacterial Vaginosis Infection.

Abroad (travel likely)RecruitingPHASE1

Conditions

Bacterial Vaginosis Treatment

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Allied Health Hub Morayfield, Brisbane, Queensland, Australia
Contact: Study coordinator (Dr Christopher Geoffrey Moller) · 0737374500
Contact: Principal Investigator (Dr Christopher Geoffrey Moller)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections

Bacterial Vaginosis · Vaginal Candidiasis

Abroad (travel likely)Recruiting

Quatre Bornes, Mauritius

Clinical Protocol CERN Feasibility Study

Bacterial Vaginosis · Fungal Vaginal Infections

Abroad (travel likely)Recruiting

Irvine, United States · Orange, United States

A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

Bacterial Vaginosis

Abroad (travel likely)RecruitingPHASE4

Shenzhen, China

Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiases · Vulvovaginal Candidiasis, Genital · Vulvovaginal Candidiasis (VVC)

Abroad (travel likely)RecruitingPHASE3

Mobile, United States · Phoenix, United States